VINTABIO
VintaBio offers cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations. VintaBio is a life sciences business with unparalleled industry knowledge that is assisting in the alleviation of the viral vector bottleneck in cell and gene therapy development.
VINTABIO
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.vintabio.com
Total Employee:
11+
Status:
Active
Contact:
+1 (215) - 735 - 6986
Email Addresses:
[email protected]
Total Funding:
64 M USD
Technology used in webpage:
Euro Fastly Hosted
Similar Organizations
Alvotech
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Augustine Therapeutics
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
AusperBio
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Brightseed
Brightseed features artificial intelligence that reveals powerful compounds hidden in nature.
Cellares
Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
Oragenics
Oragenics develops oral probiotic products and antibiotics for humans and companion pets.
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a digital biology company, developing a drug discovery platform and pipeline with machine learning.
Somai Pharmaceuticals Ltd
Somai is a European pharmaceutical and biotech company concentrating on cannabinoid-containing pharmaceutical medicines.
Wave Life Sciences
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Current Employees Featured
Founder
Investors List
Decheng Capital
Decheng Capital investment in Venture Round - VintaBio
Key Employee Changes
| Date | New article |
|---|---|
| 2023-08-16 | VintaBio Names Jennifer Kingsley Chief Commercial Officer |
Official Site Inspections
http://www.vintabio.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VintaBio"
VintaBio- Viral Vectors Made Accessible
VintaBio was founded by innovators with unique insights and know-how. Our capabilities (RUO) Vector material. Under the direction of our founder, Dr. Shangzhen Zhou, we produce high …See details»
About - VintaBio
VintaBio was founded on the principle that high quality vectors should never be a barrier to the gene therapy industry. Our core expertise lies in the development and production of reliable …See details»
VintaBio - Crunchbase Company Profile & Funding
VintaBio offers cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations. VintaBio is a life sciences business with unparalleled industry knowledge that is assisting in the alleviation of the viral …See details»
VintaBio Company Profile 2024: Valuation, Funding & Investors
The organization understands GMP manufacturing from proof of concept to clinical trial and biologics license application in producing GMP-grade and research-grade viral vectors, …See details»
Vinta Bio | Scientist.com
VintaBio is a Cell and Gene Therapy Contract Manufacturing and Development Organization (CDMO) located in Philadelphia, PA. VintaBio specializes in developing and manufacturing …See details»
Cell Therapy Pioneers Team Up to Found Viral Vector CDMO …
Apr 11, 2023 On Tuesday, VintaBio revealed $64 million in financing and a new Philadelphia manufacturing facility. The young contract development manufacturing organization (CDMO) …See details»
VintaBio Unveils $64M to Back Viral Vector Trailblazers …
Apr 11, 2023 VintaBio's $64 million in funding, led by Decheng Capital, helped support the development of its now-open 22,500-square-foot Philadelphia facility, designed specifically to streamline cell and ...See details»
VintaBio - Funding, Financials, Valuation & Investors - Crunchbase
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
Our Approach - VintaBio
Resetting the baseline in CDMO Partnerships We are committed to the success of our visionary partners. Our personalized approach offers support at every stage of the development journey …See details»
VintaBio Emerges with $64 Million to Manufacture …
Apr 11, 2023 VintaBio has emerged from stealth with $64 million in funding and a custom-built manufacturing facility to help alleviate the viral vector bottleneck in cell and gene therapy development. Led by Decheng Capital, the funding …See details»
VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the ...
"VintaBio comes with the highest degrees of specialism and industry experience in a field of retrofitted, generalist operations. This focus and world-class expertise was the reason we …See details»
About – vintabio
Dr. Shangzhen Zhou, M.D., is the co-founder and Chief Technology Officer (CTO) of VintaBio bringing more than 34 years of experience in gene therapy to the company. Dr. Zhou earned …See details»
VintaBio, aiming to meet cell and gene therapy manufacturing …
Apr 11, 2023 Another life sciences company is launching in Philadelphia: VintaBio came out of “stealth” mode Tuesday with the announcement of a $64 million investment led by Decheng …See details»
VintaBio
VintaBio. Exhibitor. Vinta Bio provides Cell and Gene Therapy manufacturing services to organizations that are developing drugs for use in clinical trials. Vinta Bio has experienced …See details»
Facility - VintaBio
VintaBio rigorously considers all aspects of the process to ensure that our production process is as efficient and reliable as possible. With our small footprint process, we strive to be the lowest …See details»
VintaBio Unveils $64M to Back Approved Cell & Gene Therapies
Apr 12, 2023 VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck in cell and gene therapy development, today emerged from …See details»
VintaBio Unveils $64M to Back Viral Vector ... - Markets Insider
Apr 11, 2023 Radspinner joins VintaBio from ILC Dover, a New Mountain Capital portfolio company, where he served as president for the organization's biotherapeutics portfolio.See details»
VintaBio Unveils $64M to Back Viral Vector Trailblazers ... - BioSpace
Apr 11, 2023 VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck in cell and gene therapy development, emerged from …See details»
Our Capabilities - VintaBio
As part of our cGMP service, VintaBio offers CMC support services to support your IND application and pre-BLA submission. Our manufacturing process is understood and thoroughly …See details»
FAQs - VintaBio
Our process offers reliability and consistency by using VintaBio’s proprietary cell line and production platform from the research vectors through clinical vectors, helping turn your …See details»